Chemical Biology of Proteostasis
Jack Taunton, PhD, Professor, Department of Cellular and Molecular Pharmacology, University of California San Francisco
New Ways of Targeting K-Ras
Frank McCormick, PhD, Professor, HDF Comprehensive Cancer Center, University of California San Francisco
About the Event
Cambridge Healthtech Institute's 13th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates,
this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent meeting tracks.
New for 2018 is expanded
coverage of Small Molecules for Cancer Immunotherapy, plus new coverage of Ubiquitin Proteasome System Inhibitors, Targeting Complex Membrane Proteins, as well as Lead Optimization for Drug Safety.
Event Features
- More than 150 presentations
- 750+ high-level participants
- 70+ posters
- Interactive roundtable, breakout & panel discussions
- “Track-hop” between concurrent meetings
- Exclusive exhibit & poster viewing hours
- Dedicated networking opportunities
Contact Us
PROGRAMMING
INFORMATION
Anjani Shah, Ph.D.Conference Director and Team Lead
Cambridge Healthtech Institute
Phone: (+1) 781-247-6252
Email:
ashah@healthtech.com
SPONSORSHIP &
EXHIBITS
Carolyn BentonBusiness Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412
Email:
cbenton@healthtech.com ;
MEDIA & ASSOCIATION PARTNERSHIPS
Dave MelloDirector of Product Marketing
Cambridge Healthtech Institute
Phone: (+1) 781-972-5485
Email:
dmello@healthtech.com